Search research articles
Contact Us
Filters
Showing results (41-50 of 77) with videos related to
Page
of 8
Sort By:
Arthritis and Rheumatism
|
March 2, 2011
Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritis
Berit Grandaunet, Silje W Syversen, Mari Hoff, et al.
Haematologica
|
May 12, 2004
A low serum level of soluble tumor necrosis factor receptor p55 predicts response to thalidomide in advanced multiple myeloma
Anne-Tove Brenne, Lene Hejna Romstad, Peter Gimsing, et al.
Journal of Hematology & Oncology
|
September 2, 2016
Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro
Thea Kristin Våtsveen, Anne-Marit Sponaas, Erming Tian, et al.
Cell Communication and Signaling : CCS
|
June 7, 2015
Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B
Oddrun Elise Olsen, Karin Fahl Wader, Hanne Hella, et al.
Circulation
|
February 13, 2002
Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4
Brit Dybdahl, Alexander Wahba, Egil Lien, et al.
Experimental Hematology
|
March 19, 2013
HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase
Torstein Baade Rø, Toril Holien, Unn-Merete Fagerli, et al.
Oncotarget
|
September 30, 2016
Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells
Katarzyna Baranowska, Kristine Misund, Kristian K Starheim, et al.
European Journal of Haematology
|
February 4, 2009
c-Met signaling promotes IL-6-induced myeloma cell proliferation
Håkon Hov, Erming Tian, Toril Holien, et al.
Plos One
|
August 13, 2013
Targeting proliferating cell nuclear antigen and its protein interactions induces apoptosis in multiple myeloma cells
Rebekka Müller, Kristine Misund, Toril Holien, et al.
The Journal of Biological Chemistry
|
July 28, 2006
Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro
Achilleas D Theocharis, Carina Seidel, Magne Borset, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 77) with videos related to
Sort By:
Page
of 8
Arthritis and Rheumatism
|
March 2, 2011
Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritis
Berit Grandaunet, Silje W Syversen, Mari Hoff, et al.
Haematologica
|
May 12, 2004
A low serum level of soluble tumor necrosis factor receptor p55 predicts response to thalidomide in advanced multiple myeloma
Anne-Tove Brenne, Lene Hejna Romstad, Peter Gimsing, et al.
Journal of Hematology & Oncology
|
September 2, 2016
Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro
Thea Kristin Våtsveen, Anne-Marit Sponaas, Erming Tian, et al.
Cell Communication and Signaling : CCS
|
June 7, 2015
Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B
Oddrun Elise Olsen, Karin Fahl Wader, Hanne Hella, et al.
Circulation
|
February 13, 2002
Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4
Brit Dybdahl, Alexander Wahba, Egil Lien, et al.
Experimental Hematology
|
March 19, 2013
HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase
Torstein Baade Rø, Toril Holien, Unn-Merete Fagerli, et al.
Oncotarget
|
September 30, 2016
Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells
Katarzyna Baranowska, Kristine Misund, Kristian K Starheim, et al.
European Journal of Haematology
|
February 4, 2009
c-Met signaling promotes IL-6-induced myeloma cell proliferation
Håkon Hov, Erming Tian, Toril Holien, et al.
Plos One
|
August 13, 2013
Targeting proliferating cell nuclear antigen and its protein interactions induces apoptosis in multiple myeloma cells
Rebekka Müller, Kristine Misund, Toril Holien, et al.
The Journal of Biological Chemistry
|
July 28, 2006
Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro
Achilleas D Theocharis, Carina Seidel, Magne Borset, et al.
Page
of 8